中国当代医药
中国当代医药杂志欢迎您 今天是   2025年4月8日星期二
设为首页  加入收藏  联系我们         
 
      首 页    |    本刊简介     |    期刊荣誉     |    编采团队     |    会务培训     |    理事单位     |    下载专区     |    在线留言     |    联系我们     |     返回中国当代医药网
中国当代医药  2022, Vol. 29 Issue (16): 107-110    
  心血管疾病 本期目录 | 过刊浏览 | 高级检索 |
经远端桡动脉与常规桡动脉行冠状动脉介入治疗老年冠心病患者的效果
周海涛 徐国欣 张德新
江苏省扬中市人民医院心内科
Effect of percutaneous coronary intervention through distal radial artery and conventional radial artery in the treatment of elderly patients with coronary heart disease
ZHOU Haitao XU Guoxin ZHANG Dexin
Department of Cardiology, Yangzhong People′s Hospital
全文: PDF (0 KB)   HTML (1 KB) 
输出: BibTeX | EndNote (RIS)      
摘要 目的 探讨经远端桡动脉与常规桡动脉行经皮冠状动脉介入(PCI)治疗老年冠心病患者的效果。 方法 选取2019年2月至2021年2月江苏省扬中市人民医院收治的78 例老年冠心病患者作为研究对象,按照随机数字表法分为对照组(39 例)与研究组(39 例)。 对照组采用常规桡动脉行PCI 治疗方法,研究组采用经远端桡动脉行PCI 治疗方法。 比较两组患者的治疗效果、治疗前后的心功能参数左室收缩末期容积(LVESV)与左室射血分数(LVEF)及术后并发症发生情况。结果 研究组的总有效率高于对照组,差异有统计学意义(P<0.05)。治疗前,两组患者的LVESV、LVEF 水平比较, 差异无统计学意义 (P>0.05)。 两组患者治疗后的LVESV 水平低于治疗前,LVEF 水平高于治疗前,且研究组患者治疗后的LVESV 水平低于对照组,LVEF 水平高于对照组,差异有统计学意义(P<0.05)。研究组患者的术后并发症总发生率低于对照组,差异有统计学意义(P<0.05)。结论 与常规桡动脉行PCI 治疗相比,经远端桡动脉行PCI 治疗年龄>60 岁冠心病患者能够明显提高效果,有利于促进心功能恢复,减少术后并发症的发生。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
周海涛
徐国欣
张德新
关键词 冠心病经远端桡动脉常规桡动脉冠状动脉介入    
Abstract:Objective To explore the effect of percutaneous coronary intervention (PCI) through distal radial artery and conventional radial artery in the treatment of elderly patients with coronary heart disease. Methods A total of 78 elderly patients with coronary heart disease treated in Yangzhong People′s Hospital of Jiangsu Province from February 2019 to February 2021 were selected as the research objects. They were divided into the control group (39 cases) and the study group (39 cases) according to random number table method. The control group was treated with conventional radial artery PCI, and the study group was treated with distal radial artery PCI. The treatment effect, cardiac function parameters, left ventricular end systolic volume (LVESV) and left ventricular ejection fraction (LVEF) before and after treatment, postoperative complications were compared between the two groups. Results The total effective rate of the study group was higher than that of the control group, the difference was statistically significant (P<0.05). There were no significant differences in the levels of LVESV and LVEF between the two groups before treatment (P>0.05). The levels of LVESV in the two groups after treatment were lower than those before treatment, and the levels of LVEF in the two groups after treatment were higher than those before treatment, and the level of LVESV in the study group after treatment was lower than that in the control group, the level of LVEF in the study group after treatment was higher than that in the control group, the differences were statistically significant (P<0.05). The total incidence of postoperative complications in the study group was lower than that in the control group, the difference was statistically significant (P<0.05).Conclusion Compared with conventional radial artery PCI, PCI through distal radial artery can significantly improve the curative effect of patients with coronary heart disease aged >60 years, promote the recovery of cardiac function and reduce the incidence of postoperative complications.
Key wordsCoronary heart disease    Through distal radial artery    Conventional radial artery    Coronary intervention
    
作者简介: 周海涛(1978-),男,汉族,黑龙江人,副主任医师,研究方向:心血管内科相关疾病。
引用本文:   
周海涛;徐国欣;张德新. 经远端桡动脉与常规桡动脉行冠状动脉介入治疗老年冠心病患者的效果[J]. 中国当代医药, 2022, 29(16): 107-110.
ZHOU Haitao; XU Guoxin ;ZHANG Dexin. Effect of percutaneous coronary intervention through distal radial artery and conventional radial artery in the treatment of elderly patients with coronary heart disease. 中国当代医药, 2022, 29(16): 107-110.
链接本文:  
https://www.dangdaiyiyao.com/CN/     或     https://www.dangdaiyiyao.com/CN/Y2022/V29/I16/107
中华人民共和国互联网药品信息服务资格证书(京)-非经营性-2016-0092
京ICP备11001767号-6  京公网安备 11010502046607号  互联网药品信息服务资格证  期刊出版许可证  广告经营许可证
信息产业部备案管理系统网址 http://beian.miit.gov.cn/state/outPortal/loginPortal.action
投稿热线:010-59626690 总机:010-59626692/18/19/20   传真:010-59626204   投稿信箱:ddyy@vip.163.com
地址:北京市朝阳区东四环中路78号楼(大成国际中心B1座)8B02室   邮编:100124
技术支持:北京玛格泰克科技发展有限公司
Copyright 2000-2014 版权所有 《中国当代医药》杂志社 未经授权请勿转载